2000
DOI: 10.1300/j094v08n03_03
|View full text |Cite
|
Sign up to set email alerts
|

A Comparison of Self-Estimated Symptoms and Impact of Disease in Fibromyalgia and Rheumatoid Arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2001
2001
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 18 publications
1
5
0
Order By: Relevance
“…It also concurs with the view that pain behavior, rather than pain per se, should be the target for treatment [50]. Our finding that FM women experienced lower PWB than the RA women can be explained by the finding that persons with FM often report more functional and psychiatric impairment than persons with RA [51, 52]. …”
Section: Discussionsupporting
confidence: 90%
“…It also concurs with the view that pain behavior, rather than pain per se, should be the target for treatment [50]. Our finding that FM women experienced lower PWB than the RA women can be explained by the finding that persons with FM often report more functional and psychiatric impairment than persons with RA [51, 52]. …”
Section: Discussionsupporting
confidence: 90%
“…The validity and reliability of the ISI has been demonstrated, 5,38 and it has been used effectively across multiple populations with comorbid disease. 58 A clinical cut-off of 10 is sensitive and specific to differentiating normal sleepers from those with clinically significant insomnia among persons with medical conditions. 38 …”
Section: Methodsmentioning
confidence: 99%
“…24,25,51,52,58 However, a recent review suggests that sleep disruption may be a more consistent predictor of the incidence and augmentation of pain severity as opposed to pain causing difficulties in sleep. 21 A possible explanation for these observations is sleep disturbance may engage multiple pain modulatory circuits within the central nervous system through inflammatory mediators or N-methyl-D-aspartate receptor activation.…”
Section: Introductionmentioning
confidence: 99%
“…The ISI was developed to be an outcomes measure for insomnia research and has frequently been used as an outcome in clinical trials, both of pharmacologic therapies and behavioral interventions (58–64). It has also been used to identify morbidity and poor outcomes associated with insomnia, including in rheumatologic diseases (65, 66).…”
Section: Insomnia Severity Index (Isi)mentioning
confidence: 99%